Webinar
Lung cancer is the deadliest cancer worldwide and the most prevalent cancer in Asia. In fact, 63% of all lung cancer cases occurred in Asia, accounting for approximately 19% of all cancer-related deaths in the region.
The treatment of lung cancer has advanced rapidly, with evidence showing that new approaches to thoracic procedures and treatments significantly improved patients' quality of life. While lobectomy remained the standard procedure for non-small cell lung cancer (NSCLC) at the time, considerable discussions emerged around the potential of segmentectomy, fueled by findings from two major clinical trials: JCOG0802 and CALGB140503.
During the Think Again seminar series, leading experts from the Asia-Pacific region shared their techniques, strategies, and insights on segmentectomy from various perspectives. Additionally, Dr. Shun-Ichi Watanabe from the National Cancer Center Hospital Central provided updates and follow-up observations from the JCOG0802 trial.
Lung cancer is the deadliest cancer worldwide and the most prevalent cancer in Asia. In fact, 63% of all lung cancer cases occurred in Asia, accounting for approximately 19% of all cancer-related deaths in the region.
The treatment of lung cancer has advanced rapidly, with evidence showing that new approaches to thoracic procedures and treatments significantly improved patients' quality of life. While lobectomy remained the standard procedure for non-small cell lung cancer (NSCLC) at the time, considerable discussions emerged around the potential of segmentectomy, fueled by findings from two major clinical trials: JCOG0802 and CALGB140503.
During the Think Again seminar series, leading experts from the Asia-Pacific region shared their techniques, strategies, and insights on segmentectomy from various perspectives. Additionally, Dr. Shun-Ichi Watanabe from the National Cancer Center Hospital Central provided updates and follow-up observations from the JCOG0802 trial.
Lung cancer is the deadliest cancer worldwide and the most prevalent cancer in Asia. In fact, 63% of all lung cancer cases occurred in Asia, accounting for approximately 19% of all cancer-related deaths in the region.
The treatment of lung cancer has advanced rapidly, with evidence showing that new approaches to thoracic procedures and treatments significantly improved patients' quality of life. While lobectomy remained the standard procedure for non-small cell lung cancer (NSCLC) at the time, considerable discussions emerged around the potential of segmentectomy, fueled by findings from two major clinical trials: JCOG0802 and CALGB140503.
During the Think Again seminar series, leading experts from the Asia-Pacific region shared their techniques, strategies, and insights on segmentectomy from various perspectives. Additionally, Dr. Shun-Ichi Watanabe from the National Cancer Center Hospital Central provided updates and follow-up observations from the JCOG0802 trial.
Video
In general, radical hysterectomy involves extensive resection, which can lead to urinary dysfunction affecting quality of life (QOL).
In this case video, Dr. Tomoyasu Kato concisely summarizes and explains the key points of nerve-sparing radical hysterectomy, which preserves pelvic nerves and minimizes bladder dysfunction.
This video presents two TLH cases. In the first case, you can learn basic surgical procedure and anatomy for TLH.
The second case presents a challenging case with a 3 kg uterus. Through these cases, you will learn our surgical concepts which are avoiding cutting through fat to prevent bleeding and sharp dissection of the connective tissue by collaboration with the assistance. The safe and proper use of advanced bipolar and hemostats are also featured.
In this video, Prof. Kim demonstrates a single-port total laparoscopic hysterectomy using ENSEAL X1, emphasizing its surgical effectiveness, procedural approach, and the setup required for single-port surgery. Gain valuable insights from experts on mastering this specialized technique for a safe and efficient procedure.